2023
DOI: 10.3390/molecules28020768
|View full text |Cite
|
Sign up to set email alerts
|

3-(Adenosylthio)benzoic Acid Derivatives as SARS-CoV-2 Nsp14 Methyltransferase Inhibitors

Abstract: SARS-CoV-2 nsp14 guanine-N7-methyltransferase plays an important role in the viral RNA translation process by catalyzing the transfer of a methyl group from S-adenosyl-methionine (SAM) to viral mRNA cap. We report a structure-guided design and synthesis of 3-(adenosylthio)benzoic acid derivatives as nsp14 methyltransferase inhibitors resulting in compound 5p with subnanomolar inhibitory activity and improved cell membrane permeability in comparison with the parent inhibitor. Compound 5p acts as a bisubstrate i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
16
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(17 citation statements)
references
References 29 publications
1
16
0
Order By: Relevance
“…Our results and the various studies published in the last two years on SARS-CoV-2 nsp14 inhibitors did not reveal any significant antiviral activity, which was unexpected given the potent nanomolar to subnanomolar inhibitions obtained on the purified enzyme [ [21] , [22] , [23] , [24] , [25] ]. Several hypotheses could explain the moderate inhibition observed.…”
Section: Resultssupporting
confidence: 59%
See 1 more Smart Citation
“…Our results and the various studies published in the last two years on SARS-CoV-2 nsp14 inhibitors did not reveal any significant antiviral activity, which was unexpected given the potent nanomolar to subnanomolar inhibitions obtained on the purified enzyme [ [21] , [22] , [23] , [24] , [25] ]. Several hypotheses could explain the moderate inhibition observed.…”
Section: Resultssupporting
confidence: 59%
“…Then, with the emergence of Covid-19, many libraries were screened on SARS-CoV-2 nsp14 but the inhibition results were rather poor [ [16] , [17] , [18] , [19] , [20] ]. In contrast, rational drug design approaches lead to the identification of much more potent inhibitors active at nanomolar [ [21] , [22] , [23] , [24] , [25] ] or subnanomolar concentration [ 25 ]. All these new inhibitors are mimics of SAM/SAH and most of them have been modeled in the crystal structure of SARS-CoV nsp14, solved in the presence of SAM (PDB 5C8T ) [ 26 ].…”
Section: Introductionmentioning
confidence: 99%
“…[17][18][19][20][21] Our group's research explored possible modifications on the purine nucleobase, 22 a strategy which has recently been used by other authors. 17,23 Intriguing result were also obtained by fragment crystallography and high-throughput screening. [24][25][26][27] Here, we follow up on our nucleobase modification study of SAH analogs and we combine it with the results obtained by substitution of the amino acid part of SAH analogues.…”
Section: Introductionmentioning
confidence: 82%
“…[6,7] In these bisubstrates, the link between the two substrates is based on a sulfonamide function [5,6,7] or various S-containing linkers (Figure 1D). [4,8,9] Optimization of the substituents on the sulfonamide led to powerful inhibitors of SARS-CoV N7-G MTases (nsp14) (IC 50 in the subnanomolar range). [10] Notably, in the latter cases, the nucleotide substrate is mimicked by an aryl group.…”
Section: Introductionmentioning
confidence: 99%